publication date: Dec. 21, 2010
In this issue:
FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer;
Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).
Download (PDF 262KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.